Key Findings:  The data provides a basis for further studies in evaluating the role of the cannabinoid and monoaminergic systems in the etiology of ASDs and whether the BTBR mice can model both schizophrenia and ASDs. The researchers note: "It is tempting to suggest the evaluation of Δ9-THC or other cannabinoids with reduced psychoactivity in irritability, tantrums and self-injurious behavior associated with autistic individuals."
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Spain, United States
Year of Pub:  2011
Cannabinoids Studied:  Tetrahydrocannabinol (THC)
Chemotype:  Chemotype I